78 results
Page 3 of 4
POSASR
y6lp 5s59y7i7aqsf
2 Mar 22
Automatic shelf registration (post-effective amendment)
9:03pm
8-K
7is89txd8aeoa83
10 Jan 22
Fulcrum Therapeutics® Announces Upcoming Milestones to Support Its Mission of Treating the Root Cause of Rare Genetic Diseases
7:07am
S-3ASR
eydizx4u8hh5 mysdzeh
4 Nov 21
Automatic shelf registration
7:46am
8-K
EX-99.1
xe02zzj9lu b4vokd
12 Aug 21
Fulcrum Therapeutics Announces Pricing of $125 Million Public Offering
4:41pm
8-K
EX-1.1
elkzhn7
12 Aug 21
Fulcrum Therapeutics Announces Pricing of $125 Million Public Offering
4:41pm
424B5
jdnq1w79l0u0
12 Aug 21
Prospectus supplement for primary offering
4:38pm
424B5
9e1lwossrwj6
11 Aug 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
eumxvv9qovfp1n aj2l
20 Jan 21
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
4:05pm
8-K
EX-1.1
aqa ih2wti3r57hzip
20 Jan 21
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
4:05pm
424B5
zbg58fh88ypm82i9a
20 Jan 21
Prospectus supplement for primary offering
4:02pm